SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is trending as the community celebrates the recovery of its ticker symbol and continues to push for broader visibility while emphasizing their commitment to an organic, long-term project. Investors are actively discussing the potential for a forthcoming chart listing and rallying around a narrative of collective building to differentiate themselves from short-term memecoin scams.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending as investors focus on its critical role as the gatekeeper of AI infrastructure, buoyed by massive order backlogs and a recent breakthrough in lithography technology that promises a 50% boost in chip output by 2030. While some market participants debate potential valuation stretching, the community remains intensely focused on the company's monopoly on EUV systems as a non-negotiable bottleneck for global semiconductor scaling.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing heightened community discussion as investors weigh its aggressive infrastructure expansion against ongoing concerns regarding potential equity dilution from its sizable at-the-market offering. The stock is currently being closely monitored for a potential breakout as traders look for news on site energizations and new hyperscaler partnerships to confirm its competitive standing within the evolving AI and data center sector.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as investors focus on its pivot to building a domestic heavy rare earth metallization facility designed to replace Chinese-sourced materials in U.S. defense supply chains. The community is actively debating the company's long-term potential as a critical defense contractor against concerns regarding its pre-revenue status and capital structure.

Sezzle, Inc. engages in the operation of a digital payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie G. Youakim, Killian Brackey and Paul V. Paradis on January 4, 2016 and is headquartered in Minneapolis, MN.

Sezzle Inc.

Sezzle is seeing intense market volatility and increased short interest following a board-level shakeup, with the community actively debating whether the resignation of a key board member signals deeper governance issues or a buying opportunity. Traders are heavily focused on the company's strong fundamentals and upcoming earnings as potential catalysts to trigger a short squeeze against a backdrop of ongoing institutional accumulation.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

Investors are actively flocking to UVIX as a hedge against rising geopolitical tensions in the Middle East and concerns over oil supply disruptions following the closure of the Strait of Hormuz. The community is heavily debating whether the current market stability is a temporary lull driven by political rhetoric or a fragile calm before a significant volatility breakout, fueling intense discussion around potential black swan events.

TOSHI

TOSHI is trending as the community debates its long-term potential as the face of the Base ecosystem, with investors actively discussing accumulation strategies during current market volatility. Sentiment is polarized, as some members express frustration over price performance while others highlight technical indicators like bullish divergences as signs of a potential reversal.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems is trending due to the anticipation of late-breaking CHOPIN trial data being presented at ESMO, alongside investor scrutiny regarding revised revenue guidance and the impact of the 340b pricing program. The community remains highly focused on the stock's long-term valuation relative to its Phase 2 pipeline progress, despite recent short-term volatility and downward pressure on price targets.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is facing significant selling pressure amid broader market volatility, compounded by recent class-action litigation and a cautious price target adjustment from analysts. While the community is actively debating the stock's long-term value and recent acquisition strategy, sentiment is polarized between long-term investors viewing current levels as a deep discount and traders wary of the ongoing technical breakdown.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

The AIRCOIN community is rallying behind a 'hold culture' narrative, fueled by significant supply locks through its 'Airlock' mechanism and daily engagement efforts. Investors are actively contrasting the project's long-term building focus and community-owned treasury against the typical volatility and 'rug-pull' risks of other memecoins.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?

Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 10, 2026 Insiders may stand to receive...

JPMorgan Chase & Co. Sells 181,285 Shares of Apellis Pharmaceuticals, Inc. $APLS

JPMorgan Chase & Co. cut its holdings in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 77.2% in the 3rd quarter, according to the company in its most recent disclosure with...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Given Average Rating of "Hold" by Analysts

Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) have received an average recommendation of "Hold" from the twenty-three brokerages that are currently covering the firm...

Gilead Expands Oncology Pipeline With $5B Tubulis Deal

Gilead's $5B Tubulis deal expands its ADC pipeline, boosting oncology ambitions as the company accelerates strategic acquisitions beyond HIV.

Apellis Pharmaceuticals, Inc. $APLS Shares Sold by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC lowered its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 61.1% in the fourth quarter, according to the company in its most recent...

SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS

SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS...

Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders?

Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders? Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 7, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

Apellis Pharmaceuticals (NASDAQ:APLS) Reaches New 12-Month High - What's Next?

Apellis Pharmaceuticals (NASDAQ:APLS) Hits New 52-Week High - Here's What Happened...

Apellis Pharmaceuticals (NASDAQ:APLS) Downgraded by Roth Mkm to "Hold"

Roth Mkm cut Apellis Pharmaceuticals from a "strong-buy" rating to a "hold" rating in a report on Thursday...

Mizuho Increases Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $41.00

Mizuho boosted their price objective on shares of Apellis Pharmaceuticals from $20.00 to $41.00 and gave the stock a "neutral" rating in a report on Thursday...

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

APLS
Apellis Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest APLS News

APLSApellis Pharmaceuticals Inc